Red Cell Distribution Width as an Independent Prognostic Biomarker in MASLD
Antioxidants · 25.08.2026 · 15 (9) · 1065
DOI: 10.3390/antiox15091065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 25.08.2026. Verfasst von Tom Ryu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, Seoul 0440…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Soonchunhyang University, The Catholic University of Korea Catholic Medical Center.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) requires practical and inexpensive tools for risk stratification. We investigated whether the red cell distribution width (RDW), a routinely available hematologic parameter, predicts adverse clinical outcomes, using data from 352,623 UK Biobank participants, including 165,700 individuals with MASLD. RDW was analyzed as both a continuous and categorical variable using Cox proportional hazards models, restricted cubic splines, inverse probability treatment weighting, landmark, competing risk, and mediation analyses. Over a median follow-up of 13.6 years, each 1% increase in RDW was independently associated with higher risks of all-cause mortality (hazard ratio [HR] 1.14), cardiovascular disease (HR 1.07), cerebrovascular disease (HR 1.07), and chronic kidney disease (HR 1.09) (all p < 0.001). These associations remained consistent across multiple sensitivity analyses, and conventional biomarkers explained a modest proportion of the observed associations. Oxidative stress, together with other systemic processes affecting erythrocyte homeostasis, represents one potential mechanism underlying these associations. Higher RDW was independently associated with adverse clinical outcomes after adjustment for routine liver and metabolic biomarkers, supporting its potential value as a readily available prognostic marker in MASLD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, Seoul 04401, Republic of Korea.
- Department of Internal Medicine, Division of Gastroenterology and Hepatology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Ji Won Han
Förderung
- Korea Health Industry Development Institute
- Soonchunhyang University
- The Catholic University of Korea Catholic Medical Center
- Ministry of Health & Welfare, Republic of Korea
- Soonchunhyang University Research Fund
- The Catholic University of Korea
Zitieren
APA
Ryu, T., Lee, J., Han, J. W., Yang, H., & Yang, K. (2026). Red Cell Distribution Width as an Independent Prognostic Biomarker in MASLD. Antioxidants, 15(9), 1065. https://doi.org/10.3390/antiox15091065
Vancouver
Ryu T, Lee J, Han JW, Yang H, Yang K. Red Cell Distribution Width as an Independent Prognostic Biomarker in MASLD. Antioxidants. 2026;15(9):1065. doi:10.3390/antiox15091065
BibTeX
@article{Ryu2026,
author = {Ryu, Tom and Lee, Jaejun and Han, Ji Won and Yang, Hyun and Yang, Keungmo},
title = {Red Cell Distribution Width as an Independent Prognostic Biomarker in MASLD},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {9},
pages = {1065},
doi = {10.3390/antiox15091065}
}
EUVIMED